P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine - PubMed (original) (raw)
. 2001 Mar;268(6):1561-7.
Affiliations
- PMID: 11248673
Free article
P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine
F Frézard et al. Eur J Biochem. 2001 Mar.
Free article
Abstract
The multidrug resistant (MDR) tumor phenotype, characterized by a decreased cellular drug accumulation is achieved by ATP-dependent extrusions of drugs from cells by P-glycoprotein (P-gp) and/or by multidrug resistance protein (MRP1). Despite the huge amount of research that has been performed on the mechanisms of P-gp-mediated efflux of drug, it is not yet known what the molecular parameters are required for a molecule to be recognized and pumped out by P-gp. Anthracyclines are weak bases and, depending on the pH, can exist either in the neutral or in the positively charged form. The aim of the work reported here was to determine which molecular form is actively pumped out by P-gp (the neutral form, the protonated form, or both), and if both, the relative efficiencies of pumping. We used spectrofluorometric methods to determine the efflux of anthracyclines in K562/Adr cells, at different intracellular and extracellular pH levels. Using 3'-deamino, 3'-hydroxyl doxorubicin (OH-DOX), which is permanently neutral, we first verified that our methodologies were accurate and that the P-gp-mediated efflux of OH-DOX would not depend on the pH being in the range 6.6--8.4. The P-gp-mediated efflux of daunorubicin (DNR) and 3'-hydroxy-4-amino (WP608) was determined at different pH values. These two drugs were chosen because: (a) the lipophilicity of the neutral forms of these two molecules is so similar that any difference in the P-gp-mediated efflux cannot be assigned to lipohilicity variation, and (b) their pKa values are different (8.4 and 7.7 for DNR and WP608, respectively), which makes it easy to obtain a large variation in the proportions of the neutral and positively charged forms. Our data show that both forms are recognized by P-gp but the neutral form is pumped about three times more efficiently than the charged form. This is corroborated by results showing the active efflux (checked at pH(i) 7.3 only) of five other anthracycline containing a basic center. We interpret these data to mean that: (a) the positive charge of anthracycline is not a necessary requirement for P-gp recognition, but that (b) the presence of a protonable basic nitrogen facilitates the processing of these compounds by MDR efflux system.
Similar articles
- Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.
Salerno M, Przewloka T, Fokt I, Priebe W, Garnier-Suillerot A. Salerno M, et al. Biochem Pharmacol. 2002 Apr 15;63(8):1471-9. doi: 10.1016/s0006-2952(02)00895-x. Biochem Pharmacol. 2002. PMID: 11996888 - The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
Mülder HS, Dekker H, Pinedo HM, Lankelma J. Mülder HS, et al. Biochem Pharmacol. 1995 Sep 28;50(7):967-74. doi: 10.1016/0006-2952(95)00221-k. Biochem Pharmacol. 1995. PMID: 7575681 - Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C, Broxterman HJ, Dubru F, Priebe W, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Mol Pharmacol. 1998 Jan;53(1):141-7. doi: 10.1124/mol.53.1.141. Mol Pharmacol. 1998. PMID: 9443942 - Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.
Garnier-Suillerot A, Marbeuf-Gueye C, Salerno M, Loetchutinat C, Fokt I, Krawczyk M, Kowalczyk T, Priebe W. Garnier-Suillerot A, et al. Curr Med Chem. 2001 Jan;8(1):51-64. doi: 10.2174/0929867013373967. Curr Med Chem. 2001. PMID: 11172692 Review. - Mechanisms of cellular anthracycline resistance in childhood acute leukemia.
Den Boer ML, Pieters R, Veerman AJ. Den Boer ML, et al. Leukemia. 1998 Nov;12(11):1657-70. doi: 10.1038/sj.leu.2401175. Leukemia. 1998. PMID: 9823938 Review.
Cited by
- Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells.
Cui Q, Cai CY, Gao HL, Ren L, Ji N, Gupta P, Yang Y, Shukla S, Ambudkar SV, Yang DH, Chen ZS. Cui Q, et al. Front Oncol. 2019 Apr 25;9:313. doi: 10.3389/fonc.2019.00313. eCollection 2019. Front Oncol. 2019. PMID: 31106148 Free PMC article. - Dysregulated pH: a perfect storm for cancer progression.
Webb BA, Chimenti M, Jacobson MP, Barber DL. Webb BA, et al. Nat Rev Cancer. 2011 Aug 11;11(9):671-7. doi: 10.1038/nrc3110. Nat Rev Cancer. 2011. PMID: 21833026 Review. - Thermodynamic characterization of the multivalent binding of chartreusin to DNA.
Barceló F, Capó D, Portugal J. Barceló F, et al. Nucleic Acids Res. 2002 Oct 15;30(20):4567-73. doi: 10.1093/nar/gkf558. Nucleic Acids Res. 2002. PMID: 12384604 Free PMC article. - Drug resistance and cellular adaptation to tumor acidic pH microenvironment.
Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Wojtkowiak JW, et al. Mol Pharm. 2011 Dec 5;8(6):2032-8. doi: 10.1021/mp200292c. Epub 2011 Oct 26. Mol Pharm. 2011. PMID: 21981633 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous